CKAP2L Promotes Non-Small Cell Lung Cancer Progression through Regulation of Transcription Elongation

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Chromosomal instability (CIN) fuels tumor progression and heterogeneity in ~80% of solid cancers, including non-small cell lung cancer (NSCLC).
• The precise molecular links between CIN and cancer progression remain largely undefined.

Purpose of the Study:

• To identify novel oncogenes driving lung cancer progression through CIN.
• To elucidate the functional role and molecular mechanisms of CKAP2L in NSCLC.

Main Methods:

• Conducted an RNAi screen targeting CIN-related genes overexpressed in lung adenocarcinoma.
• Utilized in vitro and in vivo models to assess CKAP2L's impact on cancer proliferation.
• Investigated CKAP2L's interaction with RNA Pol II and its effect on transcription elongation.
• Assessed the sensitivity of NSCLC cells to alvocidib upon CKAP2L depletion.

Main Results:

• CKAP2L was identified as a potential oncogene promoting NSCLC proliferation.
• CKAP2L directly interacts with RNA Pol II, regulating transcription elongation of critical cell cycle and signaling genes.
• Depletion of CKAP2L sensitized NSCLC cells to alvocidib, reducing proliferation and increasing cell death.

Conclusions:

• CKAP2L promotes NSCLC progression via transcriptional regulation.
• Targeting CKAP2L represents a potential therapeutic strategy to enhance treatment efficacy in NSCLC.